Main character Lilly gets transported to Everholm in search of her missing sister but finds when she gets there that everyone ...

Eli Lilly has become a household name thanks to breakthrough diabetes and obesity care medicines. The stock has trounced the broader market over the past year, and shares have become a bit pricey.

The Lilly Ledbetter Fair Pay Act of 2009 is a law enacted by Congress to bolster worker protections against pay discrimination. The Act allows individuals facing pay discrimination to seek ...

Eli Lilly’s two weight loss drugs have become blockbusters, bringing in more than $1 billion in annual revenue. Demand is growing in this market, but so is competition. These players ...

Eli Lilly and Company (NYSE: LLY) will announce its third-quarter 2024 financial results on Oct. 30, 2024. Lilly will also conduct a conference call that day with the investment community and ...

Eli Lilly (NYSE:LLY) is reportedly looking to study its popular weight-loss drug Zepbound in people who aren't considered overweight but are still at risk for developing conditions such as diabetes.

Drugmaker Eli Lilly signed an agreement with the U.K. government to support early-stage life sciences businesses in the country. As part of the collaboration, which was announced Monday at the U.K ...

Eli Lilly's long-term growth prospects have been secured by the improved supply in H2'24 and the incoming capacity additions from H1'25 onwards. This is on top of the introduction of its D2C ...

Earnings Report 1.401 USD Q3 2024 Earnings Release 10/30/2024 Earnings Report 5.419 USD Q4 2024 Earnings Release 01/30/2025 Earnings Report 5.365 USD Q1 2025 Earnings Release 04/24/2025 Earnings ...

Eli Lilly’s juggernaut diabetes and obesity drugs Mounjaro and Zepbound have been erased from the FDA’s shortage list, freeing the company from competing with compounding pharmacies that have ...